费森尤斯医疗(FMS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FMS 费森尤斯医疗

交易中 08-20 12:16:29 EDT

23.85

+0.01

+0.04%

最高23.92	最低23.65	成交量16.58万
今开23.68	昨收23.84	日振幅1.11%
总市值126.93亿	流通市值86.81亿	总股本5.32亿
成交额394.80万	换手率0.05%	流通股本3.64亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"FMS","market":"US","secType":"STK","nameCN":"费森尤斯医疗","latestPrice":23.85,"timestamp":1787242534610,"preClose":23.84,"halted":0,"volume":165764,"delay":0,"changeRate":0.00041946308724838773,"floatShares":364000000,"shares":532219370,"eps":1.911677,"marketStatus":"交易中","change":0.01,"latestTime":"08-20 12:16:29 EDT","open":23.68,"high":23.915,"low":23.65,"amount":3947951.1272719996,"amplitude":0.011116,"askPrice":23.84,"askSize":269,"bidPrice":23.83,"bidSize":134,"shortable":3,"etf":0,"ttmEps":1.911677,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1787256000000},"marketStatusCode":2,"adr":1,"adrRate":0.5,"listingDate":842932800000,"exchange":"NYSE","adjPreClose":23.84,"dividendRate":0.036061,"preHourTrading":{"tag":"盘前","latestPrice":23.7487,"preClose":23.84,"latestTime":"08:43 EDT","volume":30,"amount":714.46872,"timestamp":1787229811349,"change":-0.0913,"changeRate":-0.00383,"amplitude":0.005508},"postHourTrading":{"tag":"盘后","latestPrice":23.84,"preClose":23.84,"latestTime":"19:52 EDT","volume":3618,"amount":86253.1,"timestamp":1787183530562,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.709434,"impliedVol":0.049,"impliedVolPercentile":0.0677},"requestUrl":"/m/hq/s/FMS/wiki","defaultTab":"wiki","newsList":[{"id":"2655890487","title":"费森尤斯医疗启动BEACON-US研究项目 收集高容量血液透析滤过真实世界数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2655890487","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655890487?lang=zh_cn&edition=full","pubTime":"2026-07-30 01:53","pubTimestamp":1785347580,"startTime":"0","endTime":"0","summary":"费森尤斯医疗近期宣布启动BEACON-US研究项目，旨在系统收集高容量血液透析滤过疗法在美国透析患者中的真实世界疗效与安全性数据。医学界通常将单次治疗对流容量达到23升以上界定为高容量血液透析滤过。BEACON-US项目早期观察结果与此前多项国际研究结论一致。发表于《新英格兰医学杂志》的CONVINCE研究表明，接受高容量血液透析滤过的受试者全因死亡风险比接受传统高通量血液透析者低23%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-30/doc-inikpafc2360663.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4196","FMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648704665","title":"美股遭遇近四个月最大单周资金流出，美银Hartnett：\"卖出信号\"仍在闪烁","url":"https://stock-news.laohu8.com/highlight/detail?id=2648704665","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648704665?lang=zh_cn&edition=full","pubTime":"2026-07-03 20:23","pubTimestamp":1783081438,"startTime":"0","endTime":"0","summary":"美银表示，美股基金单周流出172亿美元，创2026年3月来新高。然而美银牛熊指标升至9.5，其极度看多触发的“卖出信号”已延续六周。芯片股剧烈动荡，费软指数两天跌11%。资金正加速流向固收资产、科技基金及日股，黄金与加密货币持续失血。","market":"other","thumbnail":"https://static.tigerbbs.com/bf9ac23bac84c629134c18540a11264a","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/bf9ac23bac84c629134c18540a11264a"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3776162","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159934","GLD","FMS","ARTY","SGUmain","518880","NUGT","BK4196","BEGS","GCmain","SGCmain","BTGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638698601","title":"费森尤斯医疗(FMS)启动新一轮股票回购计划首期方案 总回购规模约10亿欧元","url":"https://stock-news.laohu8.com/highlight/detail?id=2638698601","media":"金吾财讯","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638698601?lang=zh_cn&edition=full","pubTime":"2026-05-28 19:50","pubTimestamp":1779969058,"startTime":"0","endTime":"0","summary":"金吾财讯 | 费森尤斯医疗(FMS)周四宣布，正式启动新一轮股票回购计划第一期方案，计划总回购规模约为10亿欧元，今日启动的首期回购金额最高可达6亿欧元。根据公告，首期6亿欧元的股票回购于2026年5月28日正式开始，预计将在2026年12月15日前完成。该计划此前已于5月21日召开的年度股东大会上获得购买及使用库存股的正式授权。费森尤斯医疗表示，本轮股票回购计划是公司整体资本配置框架的核心组成部分，旨在作为常规分红(股息)的有效补充。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/Y2I4NzEzZWQyOWU1MzI2NzgyODY2NzI0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/Y2I4NzEzZWQyOWU1MzI2NzgyODY2NzI0.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"300928","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EUO","FMS","FXE","MEURmain","EURmain","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638173519","title":"费森尤斯医疗(FMS)启动总额约10亿欧元新股票回购计划 盘前扬升1.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638173519","media":"金吾财讯","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638173519?lang=zh_cn&edition=full","pubTime":"2026-05-26 19:16","pubTimestamp":1779794180,"startTime":"0","endTime":"0","summary":"金吾财讯 | 全球领先的透析产品与服务供应商费森尤斯医疗 周二宣布，计划启动一项总额约为10亿欧元的新股票回购计划。该计划将在启动后的12个月内分期分批执行。费森尤斯医疗表示，连续推出大规模回购计划，得益于公司极其强劲的经营现金流表现和严谨的财务纪律。费森尤斯医疗在短短两轮内将累计注销或回购价值20亿欧元的股票，这在欧洲传统医疗巨头中并不多见。截至发稿，费森尤斯医疗美股盘前扬升1.29%，最新报21.64美元。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250107/OTc4NDY1YzgwYTY5ZDI5OGQwMTAxMzU2NDM1Mjg5Ng==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/OTc4NDY1YzgwYTY5ZDI5OGQwMTAxMzU2NDM1Mjg5Ng==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"300801","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EURmain","EUO","FXE","FMS","MEURmain","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637107374","title":"美银Hartnett：这是自铁路泡沫以来最大的泡沫 但在抛售之前 请等待两件事发生","url":"https://stock-news.laohu8.com/highlight/detail?id=2637107374","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637107374?lang=zh_cn&edition=full","pubTime":"2026-05-24 10:03","pubTimestamp":1779588190,"startTime":"0","endTime":"0","summary":"美银首席策略师Hartnett预警：AI市值集中度已逼近1880年铁路泡沫极限，牛熊指标正式触发卖出信号。但他同时告诫投资者，在两个关键条件兑现之前，减仓为时尚早。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20260524/20260524095244_62122.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260524/20260524095244_62122.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445418.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4551","FMS","BK4585","AI","AIPO","ARTY","AGIX","AIYY","BK4587","BK4023","BK4196","BK4543","BK4528","BK4187","BK4588","SPR","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133202254","title":"财报前瞻｜费森尤斯医疗本季度营收预计下滑5.09%，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1133202254","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133202254?lang=zh_cn&edition=full","pubTime":"2026-04-28 10:22","pubTimestamp":1777342968,"startTime":"0","endTime":"0","summary":"费森尤斯医疗将于2026年05月05日发布最新季度财报，市场关注利润率修复与费用效率的延续表现。综合近期的前瞻报道与机构跟踪情况，观点整体偏多。2026年02月17日的前瞻信息指出，在营收可能小幅下行的预期下，利润率改善与费用效率变化成为一致预期的核心看点，这与上一季度息税前利润同比增长44.17%与调整后每股收益同比增长58.24%的实际表现相呼应。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前瞻｜费森尤斯医疗本季度营收预计下滑5.09%，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614816338","title":"费森尤斯医疗2025财年实现净利润11.04亿美元，同比增加89.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614816338","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2614816338?lang=zh_cn&edition=full","pubTime":"2026-02-28 00:00","pubTimestamp":1772208036,"startTime":"0","endTime":"0","summary":"2月28日，费森尤斯医疗公布财报，公告显示公司2025财年净利润为11.04亿美元，同比增加89.69%；其中营业收入为221.62亿美元，同比增加5.95%，每股基本收益为1.90美元。机构评级：截至2026年2月28日，当前有16家机构对费森尤斯医疗目标价做出预测，其中目标均价为25.78美元，其中最低目标价为18.88美元，最高目标价为36.12美元。公司简介：费森尤斯医疗是世界上最大的透析公司，截至2024年12月，在全球近3700家诊所治疗约30万名患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260228000051a72771fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260228000051a72771fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148732335","title":"财报前瞻｜费森尤斯医疗本季度营收预计小幅下滑，利润率改善成关键看点","url":"https://stock-news.laohu8.com/highlight/detail?id=1148732335","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148732335?lang=zh_cn&edition=full","pubTime":"2026-02-17 10:41","pubTimestamp":1771296089,"startTime":"0","endTime":"0","summary":"费森尤斯医疗将于2026年2月24日美股盘前发布最新季度业绩，市场普遍关注在营收持平略降背景下的利润率改善与费用效率变化。本季度一致预期显示营收同比小幅下行，但利润端上修，侧面反映服务板块的效率有望进一步改善。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前瞻｜费森尤斯医疗本季度营收预计小幅下滑，利润率改善成关键看点","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516072567","title":"美敦力、强生、雅培、西门子医疗、费森尤斯医疗、飞利浦等27大全球医疗器械和诊断企业2024年第四季度和全年财报汇总","url":"https://stock-news.laohu8.com/highlight/detail?id=2516072567","media":"全球企业动态","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516072567?lang=zh_cn&edition=full","pubTime":"2025-03-02 07:11","pubTimestamp":1740870660,"startTime":"0","endTime":"0","summary":"美敦力公布截至2025年1月25日的第三财季业绩。医疗器械及设备制造商史赛克公布2024年第四季度和全年业绩。西门子医疗公布截至2024年12月31日的财年第一财季业绩。第四季度总营收53.19亿美元，上年同期为52.06亿美元。季度调整后的EBITDA利润9.05亿欧元，上年同期为8.96亿欧元。全年归属公司股东的净利润82.77亿瑞士法郎，上年为114.98亿瑞士法郎，同比下降28%。诊断业务全年销售额143.24亿瑞士法郎，营业利润19.46亿瑞士法郎。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2025-03-02/doc-inenfmis8028388.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159883","JNJ","159891","SIEGY","FMS","09997","MDT","PHG","ABT","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516552246","title":"费森尤斯医疗2024财年实现净利润5.82亿美元，同比增加7.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516552246","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516552246?lang=zh_cn&edition=full","pubTime":"2025-03-02 00:00","pubTimestamp":1740844852,"startTime":"0","endTime":"0","summary":"3月2日，费森尤斯医疗公布财报，公告显示公司2024财年净利润为5.82亿美元，同比增加7.98%；其中营业收入为209.17亿美元，同比减少0.55%，每股基本收益为0.99美元。从资产负债表来看，费森尤斯医疗总负债184.30亿美元，其中短期债务12.62亿美元，资产负债比为1.89，流动比率为1.39。机构评级：截至2025年3月2日，当前有18家机构对费森尤斯医疗目标价做出预测，其中目标均价为24.43美元，其中最低目标价为17.32美元，最高目标价为29.16美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302000106abe2c57e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302000106abe2c57e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514099121","title":"Fresenius Medical Care(FMS.US)：2024年Q4财报实现营收54.27亿美元，前值为53.69亿美元，预期值为55.4亿美元；每股收益为0.49美元，前值为0.47美元，预期值为0.40美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514099121","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514099121?lang=zh_cn&edition=full","pubTime":"2025-02-25 21:11","pubTimestamp":1740489110,"startTime":"0","endTime":"0","summary":"Fresenius Medical Care(FMS.US)：2024年Q4财报实现营收54.27亿美元，前值为53.69亿美元，预期值为55.4亿美元；每股收益为0.49美元，前值为0.47美元，预期值为0.40美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/25211148383090.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["FMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154057062","title":"费森尤斯医疗护理2024年第四季度调整后每股收益€0.91 超出预期€0.86，销售额€50.8亿 超出预期€47.5亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1154057062","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154057062?lang=zh_cn&edition=full","pubTime":"2025-02-25 17:56","pubTimestamp":1740477374,"startTime":"0","endTime":"0","summary":"费森尤斯医疗护理报告季度每股收益0.91，超出分析师共识预期的0.86，超出幅度为5.81%。相比去年同期每股收益0.52，同比增加了75%。公司报告季度销售额为50.8亿，超出分析师共识预期的47.5亿，超出幅度为7.12%。以上内容来自Benzinga Earnings专栏，原文如下：Fresenius Medical Care  reported quarterly earnings of $0.91 per share which beat the analyst consensus estimate of $0.86 by 5.81 percent. This is a 75 percent increase over earnings of $0.52 per share from the same period last year.  The company reported quarterly sales of $5.08 billion which beat the analyst consensus estimate of $4.75 billion by 7.12","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"费森尤斯医疗护理2024年第四季度调整后每股收益€0.91 超出预期€0.86，销售额€50.8亿 超出预期€47.5亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506682906","title":"3187亿美元！美国2024年对外军售再创新纪录","url":"https://stock-news.laohu8.com/highlight/detail?id=2506682906","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506682906?lang=zh_cn&edition=full","pubTime":"2025-01-25 16:45","pubTimestamp":1737794726,"startTime":"0","endTime":"0","summary":"财联社1月25日讯 当地时间周五，美国国务院表示，2024年美国对外国政府的军事装备销售额同比飙升29%，达到创纪录的3187亿美元。美国国务院发布声明称，武器销售和转让被视为重要的美国外交政策工具，对地区和全球安全有着潜在的长期影响。在欧盟中波兰是美国军事装备的最大买家，与美国军工企业签订了600多亿美元的订单。波兰也是欧洲扩军备战最积极的国家，今年已拨出创纪录的464亿美元用于国防，占经济产出的4.7%，高于去年的3.5%。","market":"us","thumbnail":"http://n.sinaimg.cn/default/feedbackpics/transform/116/w550h366/20180418/ubGb-fzihnep5208613.png","type":0,"news_type":0,"thumbnails":["http://n.sinaimg.cn/default/feedbackpics/transform/116/w550h366/20180418/ubGb-fzihnep5208613.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-01-25/doc-inehesia0999034.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["BK4196","FMS","BK4213","GDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505045527","title":"费森尤斯医疗盘中异动 临近午盘股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505045527","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505045527?lang=zh_cn&edition=full","pubTime":"2025-01-24 00:31","pubTimestamp":1737649901,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日00时31分，费森尤斯医疗股票出现波动，股价急速上涨5.09%。截至发稿，该股报24.35美元/股，成交量10.9047万股，换手率0.02%，振幅0.86%。费森尤斯医疗股票所在的医疗设施行业中，整体涨幅为1.20%。费森尤斯医疗公司简介：Fresenius Medical Care 是世界上最大的透析公司，截至2024年年中，在全球约3750家诊所治疗超过30万名患者。Fresenius 占全球透析产品市场约35%的份额，并受益于其是全球唯一一家完全整合的透析企业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124003141a22d22df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124003141a22d22df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FMS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2486538211","title":"美敦力、强生、GE医疗、西门子医疗、费森尤斯医疗、飞利浦等28大全球医疗器械和诊断企业2024年第三季度财报汇总","url":"https://stock-news.laohu8.com/highlight/detail?id=2486538211","media":"全球企业动态","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2486538211?lang=zh_cn&edition=full","pubTime":"2024-11-28 06:47","pubTimestamp":1732747620,"startTime":"0","endTime":"0","summary":"美敦力公布截至2024年10月25日的第二财季业绩。诊断业务销售额为24.12亿美元，同比下降1.5%。西门子医疗公布截至2024年9月30日的第四财季和财年业绩。调整后的EBIT利润11.2亿欧元，上年同期为10.45亿欧元，同比增长7%。医疗器械及设备制造商史赛克公布2024年第三季度业绩。季度归属公司的净利润4.16亿美元，上年同期净亏损1200万美元。季度净亏损1280万美元，上年同期净亏损640万美元。舒万诺公布2024年第三季度业绩。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2024-11-28/doc-incxqkks6087737.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["PHG","159883","SIEGY","JNJ","MDT","09997","09996","159891","GE","FMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2482522709","title":"【经观讲堂第35期】武文强：如何健康、科学地长跑？","url":"https://stock-news.laohu8.com/highlight/detail?id=2482522709","media":"微博财经-财道工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2482522709?lang=zh_cn&edition=full","pubTime":"2024-11-12 20:28","pubTimestamp":1731414480,"startTime":"0","endTime":"0","summary":"如今，颈前伸、脊柱侧弯等姿势问题在中小学生群体中的出现比例逐年升高，已经引起家长和教育部门的关注。若出现高低肩、高低髋、颈前伸、骨盆前倾、脊柱侧弯等问题，跑者应进行专业的康复和纠正。FMS测试通过七个基础动作评估主要关节的力量、活动度和稳定性，找出运动中可能存在的薄弱环节，再进行针对性的改善训练。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/wbstock/2024-11-12/doc-incvvkhh8780888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["FMS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2482267889","title":"费森尤斯医疗2024财年第三财季实现净利润2.34亿美元，同比增加155.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482267889","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2482267889?lang=zh_cn&edition=full","pubTime":"2024-11-11 00:00","pubTimestamp":1731254428,"startTime":"0","endTime":"0","summary":"11月11日，费森尤斯医疗公布财报，公告显示公司2024财年第三财季净利润为2.34亿美元，同比增加155.01%；其中营业收入为52.29亿美元，同比减少2.63%，每股基本收益为0.40美元。机构评级：截至2024年11月11日，当前有17家机构对费森尤斯医疗目标价做出预测，其中目标均价为21.34美元，其中最低目标价为15.81美元，最高目标价为27.25美元。Fresenius 占全球透析产品市场约35%的份额，并受益于其是全球唯一一家完全整合的透析企业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000048a229e379&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000048a229e379&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2479782048","title":"费森尤斯医疗盘中异动 早盘快速下挫5.00%报19.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479782048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2479782048?lang=zh_cn&edition=full","pubTime":"2024-10-30 22:52","pubTimestamp":1730299927,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日22时52分，费森尤斯医疗股票出现波动，股价快速下挫5.00%。截至发稿，该股报19.37美元/股，成交量22.5733万股，换手率0.04%，振幅1.32%。费森尤斯医疗股票所在的医疗设施行业中，整体跌幅为1.42%。费森尤斯医疗公司简介：Fresenius Medical Care 是世界上最大的透析公司，截至2024年年中，在全球约3750家诊所治疗超过30万名患者。Fresenius 占全球透析产品市场约35%的份额，并受益于其是全球唯一一家完全整合的透析企业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030225207971a343b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030225207971a343b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","FMS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.freseniusmedicalcare.com","stockEarnings":[{"period":"1week","weight":0.0051},{"period":"1month","weight":-0.0096},{"period":"3month","weight":0.0596},{"period":"6month","weight":-0.0221},{"period":"1year","weight":-0.0456},{"period":"ytd","weight":0.0008}],"compareEarnings":[{"period":"1week","weight":-0.0044},{"period":"1month","weight":0.0363},{"period":"3month","weight":0.0355},{"period":"6month","weight":0.1155},{"period":"1year","weight":0.202},{"period":"ytd","weight":0.1278}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fresenius Medical Care AG最初于1996年8月5日成立为股份公司，并于2006年2月10日注册成为股份有限公司。该公司是世界领先的肾病患者产品和服务提供商。作为一家垂直整合的医疗技术（MedTech）和医疗服务公司，费森尤斯医疗将医疗器械工程和制造专业知识与全面的患者护理相结合。在三个运营部门，即护理交付（CD）、基于价值的护理（VBC）和护理支持（CE），公司提供全方位的医疗服务、系统、设备、技术、产品和药品，为全球肾病患者提供高质量的护理。","yearOnYearQuotes":[{"month":1,"riseRate":0.533333,"avgChangeRate":0.013378},{"month":2,"riseRate":0.466667,"avgChangeRate":-0.006573},{"month":3,"riseRate":0.666667,"avgChangeRate":0.014273},{"month":4,"riseRate":0.666667,"avgChangeRate":0.024325},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.014361},{"month":6,"riseRate":0.733333,"avgChangeRate":0.011414},{"month":7,"riseRate":0.6,"avgChangeRate":-0.003101},{"month":8,"riseRate":0.433333,"avgChangeRate":-0.025433},{"month":9,"riseRate":0.551724,"avgChangeRate":-0.00021},{"month":10,"riseRate":0.433333,"avgChangeRate":-0.007561},{"month":11,"riseRate":0.7,"avgChangeRate":0.05118},{"month":12,"riseRate":0.566667,"avgChangeRate":0.010648}],"exchange":"NYSE","name":"费森尤斯医疗","nameEN":"Fresenius Medical Care AG & Co. KGaA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"费森尤斯医疗(FMS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供费森尤斯医疗(FMS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"费森尤斯医疗,FMS,费森尤斯医疗股票,费森尤斯医疗股票老虎,费森尤斯医疗股票老虎国际,费森尤斯医疗行情,费森尤斯医疗股票行情,费森尤斯医疗股价,费森尤斯医疗股市,费森尤斯医疗股票价格,费森尤斯医疗股票交易,费森尤斯医疗股票购买,费森尤斯医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"费森尤斯医疗(FMS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供费森尤斯医疗(FMS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}